CAS RN: 2828440-25-9
2,2′-Bi-1H-imidazole, 1,1′-bis[3-(1,1-dimethylethyl)phenyl]-4,4′,5,5′-tetrahydro-4,4′-bis(2-methylpropyl)-, (4S,4’S)-
Product Availability
Choose a grade to view its available package options.
5 package records2 with current stock1 grade group
| Batch No. | Package | Availability | Warehouse | Lead Time | Inquiry |
| Batchno.20260428 |
100mg |
In stock |
Shanghai, Shenzhen, Wuhan | | Inquiry |
| Batchno.20260604 |
1g |
Out of stock |
| | Inquiry |
| Batchno.20250713 |
250mg |
In stock |
Shanghai, Shenzhen, Chengdu | | Inquiry |
| Batchno.20250110 |
50mg |
Out of stock |
| | Inquiry |
| Batchno.20260425 |
50mg / 100mg / 250mg / 1g |
Out of stock |
| 5-7 business days | Inquiry |
-
Product code:
starshine_CAS2828440-25-9
-
Purity/Analytical Methods:
>99.0%
GET A QUOTE
2828440-25-9 / (4S)-1-(3-tert-butylphenyl)-2-[(4S)-1-(3-tert-butylphenyl)-4-(2-methylpropyl)-4,5-dihydroimidazol-2-yl]-4-(2-methylpropyl)-4,5-dihydroimidazole
Standard CAS: 2828440-25-9
Multi CAS: Yes
Basic Information
CAS
2828440-25-9
Multi CAS
Yes
Molecular Formula
C34H50N4
Molecular Weight
514.800000
Exact Mass
514.403548
InChI
InChI=1S/C34H50N4/c1-23(2)17-27-21-37(29-15-11-13-25(19-29)33(5,6)7)31(35-27)32-36-28(18-24(3)4)22-38(32)30-16-12-14-26(20-30)34(8,9)10/h11-16,19-20,23-24,27-28H,17-18,21-22H2,1-10H3/t27-,28-/m0/s1
InChIKey
MJHWLPOHRVQVFJ-NSOVKSMOSA-N
Computed Properties
Structural Parameters
Heavy atom count
38
Aromatic heavy atom count
12
Fraction Csp3
0.59
Rotatable bonds
7
H-bond acceptors
4
Molar refractivity
166.33
TPSA
31.2
LogP / Solubility
WLOGP
8.25
MLOGP
7.3
XLogP3
8.9
Consensus LogP
8.15
Log S (ESOL)
-8
Class (ESOL)
Insoluble
Log S (Ali)
-9.74
Class (Ali)
Insoluble
Log S (SILICOS-IT)
-10.69
Class (SILICOS-IT)
Insoluble
ADME
GI absorption
Low
BBB permeant
No
P-gp substrate
No
CYP1A2 inhibitor
No
CYP2C19 inhibitor
Yes
CYP2C9 inhibitor
Yes
CYP2D6 inhibitor
Yes
CYP3A4 inhibitor
Yes
Drug-likeness / Medicinal Chemistry
Lipinski
No
Ghose
No
Veber
Yes
Egan
No
Muegge
No
Bioavailability score
0.17
Leadlikeness
No
Synthetic Accessibility
5.5